EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer and Aging Biomarkers: Classification, Early Detection Technologies and Emerging Research Trends

Mi-Ran Ki iD, Dong Hyun Kim, Mohamed A A Abdelhamid iD, Seung Pil Pack

Biosensors · 04.11.2025 · 15 (11) · 737

DOI: 10.3390/bios15110737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 04.11.2025. Verfasst von Mi-Ran Ki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioinformatics, Korea University, Sejong-Ro 2511, Sejong 30019, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Tumor, Aging, Early Detection of Cancer. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 872 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation of Korea, Korean Ministry of Science, Korean Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer and aging are two distinct biological processes with shared cellular pathways, such as cellular senescence, DNA damage repair, and metabolic reprogramming. However, the outcomes of these processes differ in terms of proliferation. Understanding biomarkers related to aging and cancer opens a pathway for therapeutic interventions and more effective prevention, detection, and treatment strategies. Biomarkers, ranging from molecular to phenotypic indicators, play an important role in early detection, risk assessment, and prognosis in this endeavor. This review comprehensively examines key biomarkers associated with cancer and aging, highlighting their importance in early diagnostic strategies. The review discusses recent advances in biomarker-based diagnostic technologies, such as liquid biopsy, multi-omics integration, and artificial intelligence, and emphasizes their novel potential for early detection, accurate risk assessment, and personalized therapeutic interventions in cancer and aging science. We also explore the current state of biosensor development and clinical application cases. Finally, we discuss the limitations of current early diagnostic methods and propose future research directions to enhance biomarker-based diagnostic technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBiomarkers, TumorAgingEarly Detection of CancerHumansBiomarkersBiosensing TechniquesArtificial Intelligence

Stichwörter der Autor:innen

Alzheimer’s diseasePoint-of-Careagingartificial intelligence algorithmsbiological agingbiomarkersbiosensorscancerearly detectionliquid biopsy

Substanzen

Biomarkers, TumorBiomarkers

Autor:innen und Institutionen

  • Department of Biotechnology and Bioinformatics, Korea University, Sejong-Ro 2511, Sejong 30019, Republic of Korea.
  • Institute of Industrial Technology, Korea University, Sejong-Ro 2511, Sejong 30019, Republic of Korea.
  • Biology Department, Faculty of Education and Arts, Sohar University, Sohar 311, Oman.

ORCID-Profile: Mi-Ran Ki, Mohamed A A Abdelhamid

Förderung

  • the National Research Foundation of Korea
  • Korean Ministry of Science
  • Korean Ministry of Education

Zitieren

APA

Ki, M. R., Kim, D. H., Abdelhamid, M. A. A., & Pack, S. P. (2025). Cancer and Aging Biomarkers: Classification, Early Detection Technologies and Emerging Research Trends. Biosensors, 15(11), 737. https://doi.org/10.3390/bios15110737

Vancouver

Ki MR, Kim DH, Abdelhamid MAA, Pack SP. Cancer and Aging Biomarkers: Classification, Early Detection Technologies and Emerging Research Trends. Biosensors. 2025;15(11):737. doi:10.3390/bios15110737

BibTeX
@article{Ki2025,
  author = {Ki, Mi-Ran and Kim, Dong Hyun and Abdelhamid, Mohamed A A and Pack, Seung Pil},
  title = {Cancer and Aging Biomarkers: Classification, Early Detection Technologies and Emerging Research Trends},
  journal = {Biosensors},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {737},
  doi = {10.3390/bios15110737}
}
Kostenlos starten →